Publicaciones en las que colabora con DIEGO RINCÓN RODRÍGUEZ (37)

2023

  1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

2022

  1. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history

    United European Gastroenterology Journal, Vol. 10, Núm. 8, pp. 805-816

2021

  1. HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

    Transplant International, Vol. 34, Núm. 11, pp. 2214-2225

2019

  1. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients

    Liver Transplantation, Vol. 25, Núm. 8, pp. 1177-1186

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

2017

  1. Real-world multicenter experience of immunosuppression minimization among 661 liver transplant recipients

    Annals of Transplantation, Vol. 22, pp. 265-275

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  2. Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation

    Therapeutic Apheresis and Dialysis, Vol. 20, Núm. 2, pp. 189-196

2015

  1. Antifungal stewardship in a tertiary-care institution: A bedside intervention

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 492.e1-492.e9

  2. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18

2014

  1. Evaluation of antifungal use in a tertiary care institution: Antifungal stewardship urgently needed

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 7, pp. 1993-1999

  2. Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

    Liver International, Vol. 34, Núm. 10, pp. 1504-1512

2013

  1. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis

    Scandinavian Journal of Gastroenterology, Vol. 48, Núm. 4, pp. 487-495

  2. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26, Núm. 3, pp. 189-192

2010

  1. Influencia del tratamiento del hepatocarcinoma antes del trasplante hepático en la recurrencia tumoral y supervivencia postrasplante

    Gastroenterologia y Hepatologia, Vol. 33, Núm. 3, pp. 155-164

2009

  1. High rate of infection and immune disorders in patients with hepatitis C virus after liver transplantation: Short communication

    Transplant Infectious Disease, Vol. 11, Núm. 4, pp. 367-372

  2. Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients

    World Journal of Gastroenterology, Vol. 15, Núm. 38, pp. 4781-4787

  3. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodiesafter liver transplantation

    Liver Transplantation, Vol. 15, Núm. 5, pp. 530-539

  4. Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence: Short communication

    Transplant Infectious Disease, Vol. 11, Núm. 2, pp. 183-188